Talk:-Main Page-

Mika - 3 users in this website.

Andrew technically 4, if you count the guy who made communism, which got deleted, but we are basically the main 3 users.

Mika - It’s gotta be Carbon

Andrew - isn’t that heterdontosaurs’ alternate account?

Mika - Yes, this counts as a user (maybe?)

Andrew - Yeah, idk if alts count as “separate users” but ok

I love this rebrand

)

Thanks Heterodontosaurus 15:29, 21 November 2024 (UTC)

Next Page

Mika - Did you draw Australia’s portrait? (I can’t see your google drive because it’s banned in China, yes I lived in China right now)

Heterodontosaurus - yep.

Mika - imma create this for you

Mika - Pls upload File:Australia.png

Heterodontosaurus - ok

Did you draw Earth’s portraits?

Mika - Did you?

andrew - he did I think, but I wanna make the next page

Mika - Same

Heterodontosaurus - so what’s the next page gonna be

Mika - Earth, did you draw its portrait?

andrew - I made Kazakhstan and yes, I checked Heterodontosaurs’ arts, and he drew Kazakhstan.

Mika - I saw him drew Earth.

Heterodontosaurus - so, Kazakhstan is next then. We can do Earth after we made Kazakhstan decent.

bro

andrew - if 97104 raids this wiki I will be mad.

Heterodontosaurus - I can just ban him if he comes

andrew - yeah, he is SO obsessed with Squidward. He adds Sigma Cult to every countryball-related wiki.

Poll

Mika - no

andrew - nah let’s keep it as union of Soviet socialist republics

Heterodontosaurus - ok

kinda off-topic but

andrew - I found a dead country wiki, but not that dead, I mean the admin is inactive.

Heterodontosaurus - show me

andrew - Here. https://countries.fandom.com/wiki/The_Countries_Wiki Someone needs to make a new wiki but I cant because they banned me from making wikis.

andrew - yeah, there is a couple off topic pages, vandalism, no administration… yeah someone needs to make a new wiki.

Have you draw Sweden’s portrait yet?

Mika - Did you?

andrew - I saw his arts and I didn’t see Sweden so probably unfortunately not, but I am not Heterodontosaurs, so take what I said with a grain of Salt!

Heterodontosaurus - Andrew is right, I haven’t yet.

1

After u finish State of Lu, are you going to make page about Prc. - Mika (talk) 16:13, 17 August 2024 (UTC)

Not quite yet, I have special plans for PRC - Heterodontosaurus 17:44, 17 August 2024 (UTC)

Alright

Anyway, Uruguay is done now, replace it with Chile - AndrewMapping (talk) 20:38, 25 August 2024 (UTC)

Replace Qatar with UAE AndrewMapping (talk) 23:55, 31 August 2024 (UTC)

wow

This wiki is so hardworking. - AndrewMapping (talk) 20:08, 22 September 2024 (UTC)

5 users in this website.

do you actually plan on helping on this website? and why did you put a template that doesn't even exist?

IDK. AndrewMapping (talk) 11:52, 10 October 2024 (UTC)

Welp. The icon revamp is done :)

hey

Do ya mind replacing UAE with Iraq? Because it’s gonna be a while before the history is decent. AndrewMapping (talk) 20:22, 17 October 2024 (UTC)

hmmm, maybe help me building these articles? Heterodontosaurus 00:05, 18 October 2024 (UTC)

About creating India

When will India be created? Mika (talk) 13:10, 19 October 2024 (UTC)

About creating Papua New Guinea

Did the creator draw Papua New Guinea yet? It would be so fun to write the information about it being cannibal and draw of it being cannnibal. Mika (talk) 20:34, 13 November 2024 (UTC)

No, I did not draw Papua New Guinea yet, sorry. Heterodontosaurus 23:40, 13 November 2024 (UTC)

Maybe make it as User:Mika/Paupa New Guinea if you wanna make a page about that.

yes, then when I do draw Papua New Guinea your page can be used. -heterodontosaurus

btw, how do u do the diagonal two colors in the theme like Bhutan has? - Mika (talk) 20:14, 14 November 2024 (UTC)

Discord Server

- Is there any discord server for this wiki? Not yet

Stroke Prevention: Exploring the Atrial Appendage Occluder Market

The Critical Role of Atrial Appendage Occlusion

The Atrial Appendage Occluder market focuses on devices designed to prevent strokes in patients with non-valvular atrial fibrillation (AFib), a common heart rhythm disorder. In individuals with AFib, blood can pool and form clots in the left atrial appendage (LAA), a small pouch connected to the left atrium of the heart. If these clots dislodge, they can travel to the brain, causing a stroke. For patients who cannot tolerate long-term oral anticoagulants due to bleeding risks, or for whom anticoagulation is contraindicated, LAA occlusion offers a vital alternative. These devices physically seal off the LAA, reducing the risk of clot formation and subsequent embolic stroke, thereby enhancing patient safety and quality of life.

https://www.marketresearchfuture.com/reports/atrial-appendage-occluder-market-37050

Driving Factors and Patient Needs

Several factors contribute to the expansion of the Atrial Appendage Occluder market. The increasing global prevalence of atrial fibrillation, driven by an aging population and rising rates of cardiovascular risk factors, creates a substantial patient pool in need of stroke prevention strategies. A significant portion of AFib patients are at high risk for bleeding with traditional oral anticoagulants, making LAA occlusion an attractive and necessary alternative. Growing awareness among both cardiologists and patients about the benefits of LAA occlusion as a minimally invasive, non-pharmacological approach to stroke prevention is also a key market driver. Favorable clinical outcomes and expanding reimbursement coverage further support market growth.

Technological Advancements and Device Innovations

The Atrial Appendage Occluder market is characterized by ongoing technological innovation, leading to the development of safer and more effective devices. The WATCHMAN device (Boston Scientific) has been a pioneering technology, and its subsequent generations, like the WATCHMAN FLX Pro, feature enhanced designs for improved conformability, seal, and deployability. Other notable devices include the Amplatzer Amulet (Abbott Laboratories), which offers different sizing and sealing characteristics, providing more options for diverse LAA anatomies. Innovations focus on developing devices with better sealing capabilities, reduced procedural complexity, enhanced long-term stability, and improved navigation and deployment systems. Materials science advancements also contribute to more biocompatible and durable implants.

Procedural Aspects and Clinical Evidence

Percutaneous left atrial appendage occlusion procedures are typically performed in a cardiac catheterization laboratory, utilizing transesophageal echocardiography or intracardiac echocardiography for guidance. The procedure involves delivering the occluder device through a catheter, positioning it precisely within the LAA to seal it off. A robust body of clinical evidence from randomized controlled trials and real-world registries has demonstrated the safety and efficacy of LAA occlusion in preventing strokes in high-risk AFib patients. These studies have provided the foundation for regulatory approvals and widespread clinical adoption, establishing LAA occlusion as a valid and important treatment option in cardiovascular care pathways.

Future Outlook and Emerging Directions

The future of the Atrial Appendage Occluder market is bright, with continued growth anticipated due to the increasing burden of AFib and the expanding indications for LAA occlusion. Research is ongoing to develop next-generation devices with even greater ease of use, broader anatomical applicability, and potentially even lower complication rates. The development of epicardial LAA occlusion devices, which approach the appendage from the outside of the heart, offers alternatives for certain patient populations. Furthermore, the integration of advanced imaging technologies and artificial intelligence for pre-procedural planning and intra-procedural guidance will likely enhance precision and safety. As the understanding of AFib management evolves, atrial appendage occluders will remain a critical tool in the comprehensive strategy to prevent stroke. InsightRx (talk) 06:57, 17 June 2025 (UTC)